Chapter/Section Purchase

1 Obsessive-Compulsive Disorder Medicine Market Overview
1.1 Product Overview and Scope of Obsessive-Compulsive Disorder Medicine
1.2 Obsessive-Compulsive Disorder Medicine Segment by Type
1.2.1 Global Obsessive-Compulsive Disorder Medicine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 NMDA Receptor Blockers
1.2.3 Antipsychotics
1.2.4 Antidepressants
1.3 Obsessive-Compulsive Disorder Medicine Segment by Application
1.3.1 Global Obsessive-Compulsive Disorder Medicine Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.3.5 Others
1.4 Global Obsessive-Compulsive Disorder Medicine Market Size Estimates and Forecasts
1.4.1 Global Obsessive-Compulsive Disorder Medicine Revenue 2017-2028
1.4.2 Global Obsessive-Compulsive Disorder Medicine Sales 2017-2028
1.4.3 Obsessive-Compulsive Disorder Medicine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Obsessive-Compulsive Disorder Medicine Market Competition by Manufacturers
2.1 Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Obsessive-Compulsive Disorder Medicine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Obsessive-Compulsive Disorder Medicine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Obsessive-Compulsive Disorder Medicine Manufacturing Sites, Area Served, Product Type
2.5 Obsessive-Compulsive Disorder Medicine Market Competitive Situation and Trends
2.5.1 Obsessive-Compulsive Disorder Medicine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Obsessive-Compulsive Disorder Medicine Players Market Share by Revenue
2.5.3 Global Obsessive-Compulsive Disorder Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Obsessive-Compulsive Disorder Medicine Retrospective Market Scenario by Region
3.1 Global Obsessive-Compulsive Disorder Medicine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Obsessive-Compulsive Disorder Medicine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Obsessive-Compulsive Disorder Medicine Market Facts & Figures by Country
3.3.1 North America Obsessive-Compulsive Disorder Medicine Sales by Country
3.3.2 North America Obsessive-Compulsive Disorder Medicine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Obsessive-Compulsive Disorder Medicine Market Facts & Figures by Country
3.4.1 Europe Obsessive-Compulsive Disorder Medicine Sales by Country
3.4.2 Europe Obsessive-Compulsive Disorder Medicine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Obsessive-Compulsive Disorder Medicine Market Facts & Figures by Region
3.5.1 Asia Pacific Obsessive-Compulsive Disorder Medicine Sales by Region
3.5.2 Asia Pacific Obsessive-Compulsive Disorder Medicine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Obsessive-Compulsive Disorder Medicine Market Facts & Figures by Country
3.6.1 Latin America Obsessive-Compulsive Disorder Medicine Sales by Country
3.6.2 Latin America Obsessive-Compulsive Disorder Medicine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Obsessive-Compulsive Disorder Medicine Market Facts & Figures by Country
3.7.1 Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales by Country
3.7.2 Middle East and Africa Obsessive-Compulsive Disorder Medicine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Obsessive-Compulsive Disorder Medicine Historic Market Analysis by Type
4.1 Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Type (2017-2022)
4.2 Global Obsessive-Compulsive Disorder Medicine Revenue Market Share by Type (2017-2022)
4.3 Global Obsessive-Compulsive Disorder Medicine Price by Type (2017-2022)
5 Global Obsessive-Compulsive Disorder Medicine Historic Market Analysis by Application
5.1 Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Application (2017-2022)
5.2 Global Obsessive-Compulsive Disorder Medicine Revenue Market Share by Application (2017-2022)
5.3 Global Obsessive-Compulsive Disorder Medicine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sun pharmaceuticals industry Ltd.
6.1.1 Sun pharmaceuticals industry Ltd. Corporation Information
6.1.2 Sun pharmaceuticals industry Ltd. Description and Business Overview
6.1.3 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Product Portfolio
6.1.5 Sun pharmaceuticals industry Ltd. Recent Developments/Updates
6.2 H.Lunderbeck A/S
6.2.1 H.Lunderbeck A/S Corporation Information
6.2.2 H.Lunderbeck A/S Description and Business Overview
6.2.3 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Product Portfolio
6.2.5 H.Lunderbeck A/S Recent Developments/Updates
6.3 Eli Lilly and company
6.3.1 Eli Lilly and company Corporation Information
6.3.2 Eli Lilly and company Description and Business Overview
6.3.3 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Product Portfolio
6.3.5 Eli Lilly and company Recent Developments/Updates
6.4 Apotex Inc.
6.4.1 Apotex Inc. Corporation Information
6.4.2 Apotex Inc. Description and Business Overview
6.4.3 Apotex Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Apotex Inc. Obsessive-Compulsive Disorder Medicine Product Portfolio
6.4.5 Apotex Inc. Recent Developments/Updates
6.5 Viatris Inc.
6.5.1 Viatris Inc. Corporation Information
6.5.2 Viatris Inc. Description and Business Overview
6.5.3 Viatris Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Viatris Inc. Obsessive-Compulsive Disorder Medicine Product Portfolio
6.5.5 Viatris Inc. Recent Developments/Updates
6.6 Lannett
6.6.1 Lannett Corporation Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Lannett Obsessive-Compulsive Disorder Medicine Product Portfolio
6.6.5 Lannett Recent Developments/Updates
6.7 GlaxoSmithKline Plc.
6.6.1 GlaxoSmithKline Plc. Corporation Information
6.6.2 GlaxoSmithKline Plc. Description and Business Overview
6.6.3 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Product Portfolio
6.7.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.8 Alvogen
6.8.1 Alvogen Corporation Information
6.8.2 Alvogen Description and Business Overview
6.8.3 Alvogen Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Alvogen Obsessive-Compulsive Disorder Medicine Product Portfolio
6.8.5 Alvogen Recent Developments/Updates
6.9 Pfizer Inc.
6.9.1 Pfizer Inc. Corporation Information
6.9.2 Pfizer Inc. Description and Business Overview
6.9.3 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Product Portfolio
6.9.5 Pfizer Inc. Recent Developments/Updates
6.10 Amneal Pharmaceuticals LLC.
6.10.1 Amneal Pharmaceuticals LLC. Corporation Information
6.10.2 Amneal Pharmaceuticals LLC. Description and Business Overview
6.10.3 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Product Portfolio
6.10.5 Amneal Pharmaceuticals LLC. Recent Developments/Updates
6.11 Dr. Reddy's Laboratories Ltd.
6.11.1 Dr. Reddy's Laboratories Ltd. Corporation Information
6.11.2 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Product Portfolio
6.11.5 Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Obsessive-Compulsive Disorder Medicine Description and Business Overview
6.12.3 Abbott Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Abbott Obsessive-Compulsive Disorder Medicine Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Par Pharmaceuticals
6.13.1 Par Pharmaceuticals Corporation Information
6.13.2 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Description and Business Overview
6.13.3 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product Portfolio
6.13.5 Par Pharmaceuticals Recent Developments/Updates
6.14 Sebela Pharmaceuticals
6.14.1 Sebela Pharmaceuticals Corporation Information
6.14.2 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Description and Business Overview
6.14.3 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product Portfolio
6.14.5 Sebela Pharmaceuticals Recent Developments/Updates
6.15 Mallinckrodt
6.15.1 Mallinckrodt Corporation Information
6.15.2 Mallinckrodt Obsessive-Compulsive Disorder Medicine Description and Business Overview
6.15.3 Mallinckrodt Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Mallinckrodt Obsessive-Compulsive Disorder Medicine Product Portfolio
6.15.5 Mallinckrodt Recent Developments/Updates
6.16 Lupin
6.16.1 Lupin Corporation Information
6.16.2 Lupin Obsessive-Compulsive Disorder Medicine Description and Business Overview
6.16.3 Lupin Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Lupin Obsessive-Compulsive Disorder Medicine Product Portfolio
6.16.5 Lupin Recent Developments/Updates
7 Obsessive-Compulsive Disorder Medicine Manufacturing Cost Analysis
7.1 Obsessive-Compulsive Disorder Medicine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Obsessive-Compulsive Disorder Medicine
7.4 Obsessive-Compulsive Disorder Medicine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Obsessive-Compulsive Disorder Medicine Distributors List
8.3 Obsessive-Compulsive Disorder Medicine Customers
9 Obsessive-Compulsive Disorder Medicine Market Dynamics
9.1 Obsessive-Compulsive Disorder Medicine Industry Trends
9.2 Obsessive-Compulsive Disorder Medicine Market Drivers
9.3 Obsessive-Compulsive Disorder Medicine Market Challenges
9.4 Obsessive-Compulsive Disorder Medicine Market Restraints
10 Global Market Forecast
10.1 Obsessive-Compulsive Disorder Medicine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Obsessive-Compulsive Disorder Medicine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Obsessive-Compulsive Disorder Medicine by Type (2023-2028)
10.2 Obsessive-Compulsive Disorder Medicine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Obsessive-Compulsive Disorder Medicine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Obsessive-Compulsive Disorder Medicine by Application (2023-2028)
10.3 Obsessive-Compulsive Disorder Medicine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Obsessive-Compulsive Disorder Medicine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Obsessive-Compulsive Disorder Medicine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer